Connor, Clark & Lunn Investment Management (CC&L)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Connor, Clark & Lunn Investment Management (CC&L)'s DXCM Position: Q2 2024 in Review
Connor, Clark & Lunn Investment Management (CC&L) sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,800 shares — an estimated $388K sold.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DXCM in Q4 2013 and held it in 13 quarters. The position peaked at $4.21M in Q4 2021. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.
- Connor, Clark & Lunn Investment Management (CC&L) reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
- Connor, Clark & Lunn Investment Management (CC&L) sold 2,800 DexCom shares in Q2 2024, an estimated $388K.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DexCom in Q4 2013 and held it in 13 quarters.
- Connor, Clark & Lunn Investment Management (CC&L)'s DexCom position peaked at $4.21M in Q4 2021.
- 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.